These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 22816970)

  • 1. Oops!
    Parsonnet V
    Pacing Clin Electrophysiol; 2012 Oct; 35(10):1280. PubMed ID: 22816970
    [No Abstract]   [Full Text] [Related]  

  • 2. Guidant's oops, three years later.
    Neil R
    Mater Manag Health Care; 2005 Jul; 14(7):8. PubMed ID: 16146162
    [No Abstract]   [Full Text] [Related]  

  • 3. Organisation of care for Swedish patients with an implantable cardioverter defibrillator, a national survey.
    Bolse K; Johansson I; Strömberg A
    J Clin Nurs; 2011 Sep; 20(17-18):2600-8. PubMed ID: 20964752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initial experience of subcutaneous implantable cardioverter defibrillators in Singapore: a case series and review of the literature.
    Lim TS; Tan BY; Ho KL; Lim CY; Teo WS; Ching CK
    Singapore Med J; 2015 Oct; 56(10):580-5. PubMed ID: 26512151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should implantable cardioverter-defibrillators and permanent pacemakers in patients with terminal illness be deactivated? Deactivating implantable cardioverter-defibrillators and permanent pacemakers in patients with terminal illness. An ethical distinction.
    Kay GN; Bittner GT
    Circ Arrhythm Electrophysiol; 2009 Jun; 2(3):336-9; discussion 339. PubMed ID: 19808484
    [No Abstract]   [Full Text] [Related]  

  • 6. Is defibrillation testing necessary for implantable transvenous defibrillators?: defibrillation testing should not be routinely performed at the time of implantable cardioverter defibrillator implantation.
    Healey JS; Brambatti M
    Circ Arrhythm Electrophysiol; 2014 Apr; 7(2):347-51. PubMed ID: 24736424
    [No Abstract]   [Full Text] [Related]  

  • 7. Quality of life and psychological status of patients with implantable cardioverter defibrillators.
    Thomas SA; Friedmann E; Kao CW; Inguito P; Metcalf M; Kelley FJ; Gottlieb SS
    Am J Crit Care; 2006 Jul; 15(4):389-98. PubMed ID: 16823016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is defibrillation testing necessary for implantable transvenous defibrillators?: defibrillation testing is necessary at the time of implantable cardioverter defibrillator implantation.
    Russo AM; Chung MK
    Circ Arrhythm Electrophysiol; 2014 Apr; 7(2):337-46. PubMed ID: 24736423
    [No Abstract]   [Full Text] [Related]  

  • 9. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
    Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
    Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Implantable cardioverter defibrillator (ICD), automated external defibrillator (AED)].
    Kobayashi Y
    Nihon Rinsho; 2011 Sep; 69 Suppl 7():455-60. PubMed ID: 22519033
    [No Abstract]   [Full Text] [Related]  

  • 11. Beam profile disturbances from interactions with implantable pacemakers and implantable cardioverter-defibrillators.
    Gossman MS; Blohm CM
    Med Dosim; 2013; 38(2):109. PubMed ID: 23290193
    [No Abstract]   [Full Text] [Related]  

  • 12. Remote Monitoring of Implantable Defibrillators: Reducing Hospitalizations and Saving Lives?
    Gillis AM
    Circ Arrhythm Electrophysiol; 2015 Oct; 8(5):1010-1. PubMed ID: 26487620
    [No Abstract]   [Full Text] [Related]  

  • 13. In-vivo testing of digital cellular telephones in patients with implantable cardioverter-defibrillators.
    Chiladakis JA; Davlouros P; Agelopoulos G; Manolis AS
    Eur Heart J; 2001 Aug; 22(15):1337-42. PubMed ID: 11465966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Design of EMC Test System for Implantable Cardiac Pacemakers and Implantable Cardioverter Defbrillators].
    Zhang W; Zhang Z
    Zhongguo Yi Liao Qi Xie Za Zhi; 2017 Jul; 41(4):259-263. PubMed ID: 29862784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perioperative management of implantable cardioverter defibrillators.
    De Silva S
    J Perioper Pract; 2018; 28(1-2):31-32. PubMed ID: 29376778
    [No Abstract]   [Full Text] [Related]  

  • 16. The development and application of the implantable cardioverter defibrillator.
    Coats W; Politte L; Flaker GC
    Mo Med; 2010; 107(1):48-52. PubMed ID: 20222296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychosocial issues of patients with implantable cardioverter defibrillators.
    Dunbar SB
    Am J Crit Care; 2005 Jul; 14(4):294-303. PubMed ID: 15980420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-Defibrillators.
    Peterson PN; Greenlee RT; Go AS; Magid DJ; Cassidy-Bushrow A; Garcia-Montilla R; Glenn KA; Gurwitz JH; Hammill SC; Hayes J; Kadish A; Reynolds K; Sharma P; Smith DH; Varosy PD; Vidaillet H; Zeng CX; Normand ST; Masoudi FA
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29122811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implantable cardioverter-defibrillators and complications.
    Marymount JH; Rozner MA
    N Engl J Med; 2004 Feb; 350(7):734-5; author reply 734-5. PubMed ID: 14971061
    [No Abstract]   [Full Text] [Related]  

  • 20. Malfunctions of implantable cardioverter defibrillators.
    Levine PA; Kohanyi G
    JAMA; 2006 Jan; 295(2):161; author reply 161-2. PubMed ID: 16403925
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.